Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Shareholders held by Nemus Bioscience, Inc. (noted as Skye Bioscience, Inc. in metadata) on July 12, 2016. The filing details the voting results for director elections and the ratification of the independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
A total of 13,415,981 shares, representing approximately 53% of voting shares, were present at the meeting, constituting a quorum. The following matters were voted upon:
- Director Elections: All five nominees were elected for a one-year term expiring at the 2017 annual meeting. Votes were overwhelmingly in favor, with minimal votes withheld and no broker non-votes.
- Accounting Firm Ratification: Shareholders ratified the selection of Mayer Hoffman McCann P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2016, with 13,415,981 votes for, and zero against or abstaining.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Confirm the current corporate name status (Nemus Bioscience, Inc. vs. Skye Bioscience, Inc.).
- Verify the composition of the Board of Directors following the July 12, 2016 election.
- Review the subsequent financial reports audited by Mayer Hoffman McCann P.C. for the fiscal year ending December 31, 2016.